Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Niacin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 3 Bevacizumab 3 pembrolizumab 2 Magnetic Resonance Spectroscopy 2 selinexor 1 fluoromisonidazole 1 fludarabine phosphate 1 entrectinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 adagrasib 1 abemaciclib 1 X-Rays 1 Transcranial Magnetic Stimulation 1 Temozolomide 1 TPI-287 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Radiosurgery 1 Niacinamide 1 Niacin 1 Metformin 1 Mental Status and Dementia Tests 1 Magnetic Resonance Imaging 1 Lasers, Solid-State 1 Lasers 1 Glucose 1 Fertility 1 Diet, Ketogenic 1 Diet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04677049 2026-01-02

Study of Niacin in Glioblastoma

AHS Cancer Control Alberta

Phase 1/2 Suspended

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡